Show 1412: Beyond Amyloid: The Science That Could Change the Course of Alzheimer Disease

A personalized approach considering multiple factors may be helpful for changing the course of Alzheimer disease.  This week, we look at the new pharmaceuticals that the FDA has approved for treating Alzheimer disease. Although they are effective at removing amyloid plaques from the brain, they don't seem to help patients function better. Is it time to turn away from an exclusive focus on amyloid to consider other factors that might affect cognitive decline and change the course of Alzheimer disease? Our guest Dr. Dale Bredesen says he and his colleagues have identified more than 36 risk factors. He asserts that when these are addressed, people can slow or sometimes even reverse their cognitive decline. According to Dr. Bredesen, Alzheimer disease is multi-factorial and it needs a multi-pronged approach.